PJP

Invesco Dynamic Pharmaceuticals ETF
*Unless otherwise stated, data provided by FactSet.

PJP Fund Description

PJP tracks an index of US pharmaceutical companies selected and weighted based on various fundamental and risk factors.

PJP Factset Analytics Insight

PJP uses a quant-driven methodology to select and weight pharmaceutical companies based on fundamental and risk factors. Although some of the major names are represented in the portfolio, PJP’s multifactor selection process tilts the fund toward mid and small-caps resulting in a low overall weighted average market cap, typically about half of our industry benchmark. Still, its small portfolio takes concentrated stakes in some leading names. Despite a hefty expense ratio and poor tracking in comparison to peers, PJP has attracted sizable AUM and trades easily at decent spreads.

PJP MSCI ESG Analytics Insight

Invesco Dynamic Pharmaceuticals ETF has an MSCI ESG Fund Rating of BBB based on a score of 4.41 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Invesco Dynamic Pharmaceuticals ETF ranks in the 26th percentile within its peer group and in the 38th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

PJP MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PJP Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 10/21/19] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
PJP -0.29% 0.19% -7.01% -15.46% 0.29% 0.05% 14.05%
PJP (NAV) -0.32% 0.21% -6.99% -15.42% 0.32% 0.08% 14.51%
Dynamic Pharmaceutical Intellidex Index -0.28% 0.37% -6.59% -14.90% 0.89% 0.63% 14.51%
Thomson Reuters US Pharmaceuticals -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

PJP Summary Data

Invesco
06/23/05
Open-Ended Fund
0.56%
$347.20M
$2.02M
0.08%

PJP Portfolio Data

$78.32B
-10.27
2.71
1.22%
09/23/19
32

PJP Index Data

Tiered
Multi-Factor
Thomson Reuters US Pharmaceuticals

PJP Portfolio Management

0.56%
-0.64%
-0.46%
-1.52%

PJP Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

PJP Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

PJP Factset Analytics Block Liquidity

As of 10/22/19
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of PJP. PJP is rated a 5 out of 5.

PJP Tradability

35,623
$2.02M
27,333
$1.58M
0.08%
$0.04
-0.06%
0.14% / -0.24%
None
100.00%
50,000
0.55
0.02%
0.33%
57
$57.71
5

PJP Sector/Industry Breakdown


PJP
Segment Benchmark
56.83%
89.89%
10.45%
--
7.09%
--
6.67%
0.63%
5.69%
--
5.16%
0.20%
5.05%
4.83%
3.07%
--

PJP Top 10 Holdings[View All]

Amgen Inc. 4.77%
46.04%

PJP Countries


PJP
Segment Benchmark
100.00%
100.00%

PJP Regions


PJP
Segment Benchmark
100.00%
100.00%

PJP Economic Development


PJP
Segment Benchmark
100.00%
100.00%

PJP Performance Statistics

0.75
1.02
1.11
0.92
0.65%
Thomson Reuters US Pharmaceuticals

PJP MSCI ESG Ratings

BBB
4.41 / 10
38.36
26.43
--
39.42%
29.81

PJP Benchmark Comparison Holdings

32
48
21
45.49%

PJP Benchmark Comparison Summary


PJP
Segment Benchmark
32
48
$78.32B
$178.39B
-10.27
25.31
2.71
4.90
1.47%
2.63%
Medium
High

PJP Benchmark Comparison Market Cap Size


PJP
Segment Benchmark
58.95%
95.98%
15.03%
2.80%
23.89%
1.04%
2.14%
0.17%